BIT Life Sciences is proud to announce that the 2nd Annual International Congress of Cardiology (ICC-2010) with a theme of ¡°Translational Medicine to Healthcare¡± will be held during December 7-9, 2010 in Shanghai, China.
This meeting will be a dynamic forum for all cardiologists, scientists, healthcare workers, medical executives around the world who are actively involved in patient care, research and therapeutics development, including basic, translational, clinical, epidemiologic, prevention, diagnosis and drug discovery & development. The conference will provide participants a face-to-face platform to exchange ideas, share update breakthroughs and promising solutions to most important issues in the area.
This year, the aims of the congress are to provide a high quality program designed to attract delegates from all over the world; encourage these professionals to interact and in some cases forge new collaborations. The 2010 program will be a great showcase and a wonderful opportunity to hear talks from over 200 invited renowned speakers from a wide range of disciplines in the word. Their presentations will provide delegates with information on the latest development in both clinical and basic science in Cardiology.
During the past 9 years, as the ¡°Foreign Experts Databank of SAFEA-Dalian Biotechnological and Medical Experts Subdivision¡±, BIT Life Sciences has brought in 25 Nobel Prize Laureates and over 50000 foreign experts to come to China to seek collaborations. BIT will not only make contributions to the development of Science Innovation, but also take fully use of their advantages and enrich the resources to attract more foreign experts coming to China to build up the cooperation.
On behalf of BIT and organization committee of ICC-2010, we sincerely hope you could participate and contribute your invaluable experience and knowledge at this important conference.
We are looking forward to seeing you in Shanghai in December, 2010!
Sincerely Yours,
Dr. Xiaodan Mei
Executive Chair of ICC-2010
President, BIT Life Sciences, Inc